VV5.F Vext Science Inc

Healthcare Pharmaceuticals Frankfurt Exchange
0.1733 EUR
Close of Nov 12, 2026
0.0645 0.2100
Market cap
EUR 32.2M
P/E
-
P/B
0.62x
ROE
-4.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is VV5.F undervalued?

Graham number

The Graham number of Vext Science Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Vext Science Inc fundamental analysis

No fundamental analysis for Vext Science Inc yet.

Vext Science Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Vext Science Inc

Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch,…

Full company profile